These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6860724)

  • 1. d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression.
    Ettigi PG; Hayes PE; Narasimhachari N; Hamer RM; Goldberg S; Secord GJ
    Biol Psychiatry; 1983 Apr; 18(4):499-504. PubMed ID: 6860724
    [No Abstract]   [Full Text] [Related]  

  • 2. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 3. The dexamethasone suppression test in bulimia before and after successful treatment with desipramine.
    Hughes PL; Wells LA; Cunningham CJ
    J Clin Psychiatry; 1986 Oct; 47(10):515-7. PubMed ID: 3759916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 5. Dextroamphetamine and dexamethasone suppression test prediction of desipramine response.
    Faber R; Williams K; Prescott D; Bassett D; Bixler G
    Biol Psychiatry; 1989 Mar; 25(5):657-60. PubMed ID: 2920200
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.
    Nelson JC; Mazure CM; Jatlow PI
    Am J Psychiatry; 1990 Nov; 147(11):1488-92. PubMed ID: 2221161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dexamethasone suppression test and familial subtypes of unipolar depression].
    Conde López V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(4):313-23. PubMed ID: 3776731
    [No Abstract]   [Full Text] [Related]  

  • 8. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 9. Dexamethasone suppression test in depression.
    Thase ME; Neil JF; Horn TL
    Pa Med; 1984 Oct; 87(10):32, 34. PubMed ID: 6542199
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of the dexamethasone suppression test in depression.
    Charles G; Wilmotte J; Quenon M; Mendlewicz J
    Biol Psychiatry; 1982 Jul; 17(7):845-8. PubMed ID: 7115835
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of desipramine-refractory depression.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amphetamine-like reaction to the dexamethasone suppression test in depressed patients.
    Sovner R
    J Clin Psychopharmacol; 1983 Aug; 3(4):236-8. PubMed ID: 6886036
    [No Abstract]   [Full Text] [Related]  

  • 14. The dexamethasone suppression test in an elderly population.
    Tourigny-Rivard MF; Raskind M; Rivard D
    Biol Psychiatry; 1981 Dec; 16(12):1177-84. PubMed ID: 6891606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders.
    Rush AJ; Giles DE; Roffwarg HP; Parker CR
    Biol Psychiatry; 1982 Mar; 17(3):327-41. PubMed ID: 7082700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test and familial subtypes of depression--a naturalistic replication.
    Coryell W; Gaffney G; Burkhardt PE
    Biol Psychiatry; 1982 Jan; 17(1):33-40. PubMed ID: 7059637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic markers and antidepressant response.
    Ostrow DG; Okonek A; Gibbons R; Cooper R; Davis JM
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):10-3. PubMed ID: 6630160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test and response to antidepressants in depressed outpatients.
    Peselow ED; Fieve RR
    N Engl J Med; 1982 Nov; 307(19):1216-7. PubMed ID: 7121554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.